EUVIMEDEUVIMED entdecken
Open Access

Bile acid synthesis impedes tumor-specific T cell responses during liver cancer

Siva Karthik Varanasi iD, Dan Chen iD, Yingluo Liu iD, Melissa A Johnson iD, Cayla M Miller iD, Souradipta Ganguly iD, Kathryn Lande, Michael A LaPorta iD, Filipe Araujo Hoffmann, Thomas H Mann iD, Marcos G Teneche iD, Eduardo Casillas iD und 21 weitere

Science · 10.01.2025 · 387 (6730) · 192-201

DOI: 10.1126/science.adl4100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 10.01.2025. Verfasst von Siva Karthik Varanasi und 32 weiteren Autor:innen. Beteiligte Einrichtung: NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA, USA. Hauptthemen laut MEDLINE: Bile Acids and Salts, Carcinoma, Hepatocellular, CD8-Positive T-Lymphocytes, Endoplasmic Reticulum Stress. Die Arbeit wurde bisher 185-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIA NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The metabolic landscape of cancer greatly influences antitumor immunity, yet it remains unclear how organ-specific metabolites in the tumor microenvironment influence immunosurveillance. We found that accumulation of primary conjugated and secondary bile acids (BAs) are metabolic features of human hepatocellular carcinoma and experimental liver cancer models. Inhibiting conjugated BA synthesis in hepatocytes through deletion of the BA-conjugating enzyme bile acid–CoA:amino acid N -acyltransferase (BAAT) enhanced tumor-specific T cell responses, reduced tumor growth, and sensitized tumors to anti–programmed cell death protein 1 (anti–PD-1) immunotherapy. Furthermore, different BAs regulated CD8 + T cells differently; primary BAs induced oxidative stress, whereas the secondary BA lithocholic acid inhibited T cell function through endoplasmic reticulum stress, which was countered by ursodeoxycholic acid. We demonstrate that modifying BA synthesis or dietary intake of ursodeoxycholic acid could improve tumor immunotherapy in liver cancer model systems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bile Acids and SaltsCarcinoma, HepatocellularCD8-Positive T-LymphocytesEndoplasmic Reticulum StressImmune Checkpoint InhibitorsLiver NeoplasmsUrsodeoxycholic AcidAnimalsHumansMiceAcyltransferasesCell Line, TumorHepatocytesImmunotherapyLithocholic AcidOxidative StressProgrammed Cell Death 1 ReceptorTumor Microenvironment

Substanzen

AcyltransferasesBile Acids and SaltsImmune Checkpoint InhibitorsLithocholic AcidProgrammed Cell Death 1 ReceptorUrsodeoxycholic Acid

Autor:innen und Institutionen

  • NOMIS Center for Immunobiology and Microbial Pathogenesis, Salk Institute for Biological Studies, La Jolla, CA, USA.
  • Department of Pathology, School of Medicine, University of California San Diego, La Jolla, CA, USA.
  • Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
  • Department of Medicine, School of Medicine, University of California, San Diego, CA, USA.
  • The Razavi Newman Integrative Genomics and Bioinformatics Core Facility, Salk Institute for Biological Studies, La Jolla, CA, USA.
  • Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA.

ORCID-Profile: Siva Karthik Varanasi, Dan Chen, Yingluo Liu, Melissa A Johnson, Cayla M Miller, Souradipta Ganguly, Michael A LaPorta, Thomas H Mann, Marcos G Teneche, Eduardo Casillas, Kailash C Mangalhara, Ming Sun, Isaac J Jensen, Timothy Chen, Bianca Parisi, Shaunak Deota, Aaron Havas, H Kay Chung, Andrea Schietinger, Satchidananda Panda, April E Williams, Donna L Farber, Debanjan Dhar, Peter D Adams, Gen-Sheng Feng, Gerald S Shadel, Mark S Sundrud, Susan M Kaech

Förderung

  • NIAID NIH HHS
  • NIA NIH HHS
  • NIDDK NIH HHS
  • NCI NIH HHS
  • NCATS NIH HHS
  • NIH HHS

Zitieren

APA

Varanasi, S. K., Chen, D., Liu, Y., Johnson, M. A., Miller, C. M., Ganguly, S., Lande, K., LaPorta, M. A., Hoffmann, F. A., Mann, T. H., Teneche, M. G., Casillas, E., Mangalhara, K. C., Mathew, V., Sun, M., Jensen, I. J., Farsakoglu, Y., Chen, T., Parisi, B., …, & Kaech, S. M. (2025). Bile acid synthesis impedes tumor-specific T cell responses during liver cancer. Science, 387(6730), 192-201. https://doi.org/10.1126/science.adl4100

Vancouver

Varanasi SK, Chen D, Liu Y, Johnson MA, Miller CM, Ganguly S, et al. Bile acid synthesis impedes tumor-specific T cell responses during liver cancer. Science. 2025;387(6730):192-201. doi:10.1126/science.adl4100

BibTeX
@article{Varanasi2025,
  author = {Varanasi, Siva Karthik and Chen, Dan and Liu, Yingluo and Johnson, Melissa A and Miller, Cayla M and Ganguly, Souradipta and Lande, Kathryn and LaPorta, Michael A and Hoffmann, Filipe Araujo and Mann, Thomas H and Teneche, Marcos G and Casillas, Eduardo and Mangalhara, Kailash C and Mathew, Varsha and Sun, Ming and Jensen, Isaac J and Farsakoglu, Yagmur and Chen, Timothy and Parisi, Bianca and Deota, Shaunak and Havas, Aaron and Lee, Jin and Chung, H Kay and Schietinger, Andrea and Panda, Satchidananda and Williams, April E and Farber, Donna L and Dhar, Debanjan and Adams, Peter D and Feng, Gen-Sheng and Shadel, Gerald S and Sundrud, Mark S and Kaech, Susan M},
  title = {Bile acid synthesis impedes tumor-specific T cell responses during liver cancer},
  journal = {Science},
  year = {2025},
  volume = {387},
  number = {6730},
  pages = {192--201},
  doi = {10.1126/science.adl4100}
}
Kostenlos starten →